{"resourceId":"tanner-health-pmcardio-ems-ai-ecg-20260930","versions":[{"version":"external-2211ee8029a3c39eefd8b0a7aa687d7ac7a7c34ea7cfd323e17c3a2f08ee3ae9","resource":{"id":"tanner-health-pmcardio-ems-ai-ecg-20260930","title":"Tanner Health deploys PMcardio Queen of Hearts AI ECG across ambulances, EDs and cath lab in first U.S. commercial rollout","organization":"Tanner Health (Georgia) / Powerful Medical","sector":"Health system with 911 ambulance service / prehospital cardiac care","geography":"United States (west Georgia and east Alabama)","publishedAt":"2026-09-30","publicationDate":"2026-09-30","eventDate":"2026-09-30","sourceName":"Business Wire via FinancialContent","sourceLabel":"Joint press release on first U.S. commercial deployment of PMcardio","sourceUrl":"https://www.financialcontent.com/article/bizwire-2026-9-30-tanner-health-first-in-us-to-use-pmcardio-ai-platform-for-heart-attack-care","evidenceClass":"vendor-claim","outcomeClass":"emerging","topics":["knowledge-work","operating-model","governance-procurement"],"finding":"A Sept 30, 2026 Business Wire release says Tanner Health is the first commercial U.S. deployment of Powerful Medical's PMcardio platform, bringing the Queen of Hearts AI ECG model, FDA De Novo-authorized in September 2026, to 12-lead ECGs in Tanner ambulances and emergency departments, integrated with Epic and EMS workflows. The AI is described as secondary decision support. The release cites a prior 1,032-patient U.S. study: 553 of 601 STEMIs found from the initial ECG vs 427 by standard triage, false positives 41.8% to 7.9%. No Tanner results yet.","sledRelevance":"Brings FDA-authorized AI ECG interpretation to the 911 ambulance point of first contact in a rural U.S. region, which changes prehospital STEMI recognition and cath-lab activation workflows.","evidence":"Vendor and health-system press release; accuracy figures come from a previously published multicenter study cited by the vendor, not from this deployment. No local outcome, time-to-treatment or false-activation data.","architectureImplications":"AI ECG interpretation embedded in EMS and ED workflows and the Epic EHR; same finding visible to paramedics, emergency physicians and cardiologists.","governanceImplications":"FDA De Novo authorization gives a regulatory baseline, but medical direction must still set protocols for when AI findings may trigger cath-lab activation or destination changes.","securityPrivacyImplications":"ECG data flows across EMS, ED and EHR systems; the release does not describe data handling or vendor access.","caveats":"Launch announcement days after FDA authorization; study figures are vendor-cited; regional health-system EMS may differ from fire-based or county EMS; no cost data.","streamIds":["emergency-services"],"roles":{"sales":"Frame Tanner as the first U.S. test of FDA-authorized AI ECG at the ambulance: the cited study found 553 of 601 STEMIs versus 427 by standard triage, with far fewer false positives. That is a strong study result, but it is not Tanner's result. Position work with EMS agencies and hospitals around measuring local cath-lab activation accuracy and door-to-balloon time rather than repeating vendor claims.","engineering":"Integration runs through the ECG workflow and Epic, so the engineering questions are monitor compatibility, transmission from the ambulance, how the AI result is displayed to paramedics and the receiving team, and audit logging. Confirm what happens when connectivity drops in rural coverage gaps. Validate against the agency's own confirmed STEMI and OMI cases before letting AI findings change destination or activation.","delivery":"Treat this as a clinical protocol change, not a software install. Medical direction should write when AI findings may prompt early cardiology contact, train crews, and track false activations and missed occlusions monthly. Set a review at six months comparing against pre-deployment STEMI recognition and time-to-treatment data, and share the results with neighboring EMS agencies, since Tanner is the only U.S. commercial reference so far."},"roleDetails":{"sales":{"customerProblem":"Standard ECG criteria miss some acute occlusions and generate false cath-lab activations, especially where expertise is far away.","stakeholders":["EMS medical director","Cardiology/cath lab","ED leadership","Health system innovation office"],"discoveryQuestions":["What is your current prehospital STEMI false-activation rate?","Which monitors do crews use?","Who decides on cath-lab activation from AI output?"],"valueHypothesis":"AI ECG support may improve occlusion recognition and cut false activations if local results match published studies.","potentialEngagement":"Local validation and outcome-tracking plan for prehospital AI ECG.","unsupportedClaims":["Tanner outcome improvements (none reported)","Study accuracy applies to every EMS system","Reduced mortality"]},"engineering":{"fit":"Prehospital and ED 12-lead ECG decision support.","architectureIntegration":"ECG capture in ambulance/ED to PMcardio AI; results into Epic and shared with cardiology.","prerequisites":["Compatible ECG transmission","EHR integration","Protocol for AI findings"],"constraints":["Vendor-cited accuracy","Connectivity in rural areas","Regulated device scope"],"security":"Confirm PHI handling, vendor access and audit trail for AI reads.","proofOfValue":["Local sensitivity on confirmed occlusions","False cath-lab activation rate","First-ECG-to-treatment time"]},"delivery":{"work":"Write protocols, integrate, train crews, track outcomes.","dependencies":["Powerful Medical","Epic team","EMS and cardiology"],"ownership":"Health system cardiology with EMS medical direction.","skillsAdoption":"Paramedics learn to treat AI reads as secondary support and escalate per protocol.","governanceCheckpoints":["Protocol approval","Monthly false-activation review","Six-month outcome review"],"acceptanceCriteria":["False activation rate tracked from go-live","Every AI-flagged case reviewed against final diagnosis"],"risks":["Over-reliance on AI read","Missed cases when connectivity fails","Vendor claims taken as local evidence"]}},"retrievedAt":"2026-10-05T22:06:26-05:00","enrichedAt":"2026-10-05T22:06:26-05:00","enrichmentBasis":"retrieved source","accessibilityWorkforceImplications":"Aimed at rural patients' access to cardiac expertise; paramedics gain decision support but need training on how much weight to give it.","procurementImplications":"First-commercial-site status means few U.S. references; buyers should seek outcome data from Tanner before scaling.","operatingModelImplications":"Shared AI ECG read across the chain of care, with clinicians retaining decisions.","sourceVerification":{"responseId":"curl-fc-tanner-2026-10-05T22:06:26-05:00","openedUrl":"https://www.financialcontent.com/article/bizwire-2026-9-30-tanner-health-first-in-us-to-use-pmcardio-ai-platform-for-heart-attack-care","referenceExcerpt":"Queen of Hearts identified 553 of 601 confirmed STEMIs from the initial ECG, compared with 427 through standard triage","promptVersion":"sled-research-v4.0","model":null,"basis":"agent-reported inspection"}}}]}